Cargando…
Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
Shigellosis is leading bacterial cause of diarrhea with high prevalence in children younger than 5 years in low- and middle-income countries, and increasing number of reports of Shigella cases associated to anti-microbial resistance. No vaccines against Shigella are still licensed, but different can...
Autores principales: | Di Benedetto, Roberta, Mancini, Francesca, Caradonna, Valentina, Aruta, Maria Grazia, Giannelli, Carlo, Rossi, Omar, Micoli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690372/ https://www.ncbi.nlm.nih.gov/pubmed/38046812 http://dx.doi.org/10.3389/fmolb.2023.1284515 |
Ejemplares similares
-
Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
por: Mancini, Francesca, et al.
Publicado: (2023) -
GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against Shigella flexneri Serotype 6
por: Raso, Maria Michelina, et al.
Publicado: (2020) -
Towards a Four-Component GMMA-Based Vaccine against Shigella
por: Micoli, Francesca, et al.
Publicado: (2022) -
GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022) -
Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
por: Mancini, Francesca, et al.
Publicado: (2021)